Co-Diagnostics, Inc

(NASDAQ:CODX)

Latest On Co-Diagnostics, Inc (CODX):

Date/Time Type Description Signal Details
2023-05-12 07:50 ESTNewsCo-Diagnostics, Inc. (CODX) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 18:15 ESTNewsCo-Diagnostics GAAP EPS of -$0.20 beats by $0.03, revenue of $0.61M misses by $0.49MN/A
2023-05-11 03:27 ESTNewsCo-Diagnostics Q1 2023 Earnings PreviewN/A
2023-03-21 03:13 ESTNewsCo-Diagnostics hits 52-week low as H.C. Wainwright cuts ratingN/A
2023-03-17 07:15 ESTNewsCo-Diagnostics, Inc. (CODX) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 16:11 ESTNewsCo-Diagnostics GAAP EPS of -$0.45 misses by $0.54, revenue of $34.22M misses by $4.1MN/A
2023-03-16 01:07 ESTNewsCo-Diagnostics FY 2022 Earnings PreviewN/A
2023-02-21 22:58 ESTNewsCo-Diagnostics Is Losing Millions Per Quarter, Don't Buy On Cash Reserves AloneN/A
2022-11-22 18:18 ESTNewsCo-Diagnostics: Awaiting Evidence Of Pivot From COVID-19N/A
2022-11-11 08:05 ESTNewsCo-Diagnostics GAAP EPS of -$0.04, revenue of $5.1MN/A
2022-11-11 08:04 ESTNewsCo-Diagnostics, Inc. (CODX) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 22:21 ESTNewsCo-Diagnostics Q3 2022 Earnings PreviewN/A
2022-09-07 16:21 ESTNewsCo-Diagnostics: Hold Thesis Remains Well IntactN/A
2022-08-13 09:57 ESTNewsCo-Diagnostics, Inc.'s (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics GAAP EPS of -$0.08 misses by $0.18, revenue of $5.02M misses by $13.98MN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumesN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 07:50 ESTNewsCo-Diagnostics Q2 2022 Earnings PreviewN/A
2022-07-11 17:31 ESTNewsCo-Diagnostics spikes on shipments of monkeypox testN/A
2022-06-23 10:31 ESTNewsMonkeypox plays tick higher ahead of WHO emergency meetingN/A
2022-06-22 00:43 ESTNewsCo-Diagnostics: Well Priced, Long-Term Value Remains Too DistantN/A
2022-05-27 18:24 ESTNewsCo-Diagnostics extends gains on monkeypox test developmentN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics GAAP EPS of $0.34 beats by $0.17, revenue of $22.7M beats by $1.53MN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics up 11% in post market following quarterly top and bottom line beatsN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 21:26 ESTNewsCo-Diagnostics Q1 2022 Earnings PreviewN/A
2022-04-19 20:57 ESTNewsCo-Diagnostics' JV CoSara gets Indian regulatory clearance for hepatitis C viral load testN/A
2022-04-03 06:53 ESTNewsCo-Diagnostics: Where's Eikon?N/A
2022-03-25 18:17 ESTNewsCo-Diagnostics GAAP EPS of $1.23 beats by $0.13, revenue of $97.89M misses by $0.53MN/A
2022-03-25 18:17 ESTNewsCo-Diagnostics reports decline in 2021 net income; sets in line guidance for Q1N/A
2022-03-25 18:17 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-24 07:38 ESTNewsCo-Diagnostics FY 2021 Earnings PreviewN/A
2022-03-15 20:18 ESTNewsCo-Diagnostics announces $30M buyback programN/A
2022-02-04 02:27 ESTNewsCo-Diagnostics announces approval for Hep B test in IndiaN/A
2022-01-24 18:48 ESTNewsCo-Diagnostics: Swinging For The FencesN/A
2022-01-13 13:22 ESTNewsCo-Diagnostics JV CoSara receives clearance in India for HPV multiplex testN/A
2021-12-22 14:42 ESTNewsCo-Diagnostics to acquire all assets related to upcoming at-home/point-of-care platformN/A
2021-12-08 04:21 ESTNewsCo-Diagnostics partners with Tiicker to reach individual investorsN/A
2021-11-30 02:15 ESTNewsCo-Diagnostics up 6% as Omicron variant won't interfere with its COVID testsN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics EPS beats by $0.17, beats on revenueN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics offers full-year guidance above consensus; shares up 14% after-hoursN/A
2021-11-11 23:39 ESTNewsXPOF, CODX, AFIB and BYND among after hour moversN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2021 Earning Conference Call - Earnings Call TranscriptN/A
2021-11-11 03:51 ESTNewsCo-Diagnostics Q3 2021 Earnings PreviewN/A
2021-11-05 03:36 ESTNewsCo-Diagnostics' Logix Smart COVID-19 2-gene test approved for use in UKN/A
2021-10-07 07:26 ESTNewsCo-Diagnostics’ JV gets regulatory nod in India for Dengue/Chikungunya Multiplex TestN/A
2021-09-24 01:42 ESTNewsCo-Diagnostics undergoes corporate rebranding to reflect growthN/A
2021-09-17 16:52 ESTNewsCoSara Diagnostics gets CDSCO clearance to manufacture and sell its Saragene kitsN/A
2021-08-19 03:57 ESTNewsWhy Co-Diagnostics Is A Solid Covid-19 PlayN/A
2021-08-13 11:14 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call TranscriptN/A

About Co-Diagnostics, Inc (CODX):

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.

CODX Quotes by TradingView

See Advanced Chart

General

  • Name Co-Diagnostics, Inc
  • Symbol CODX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 39
  • Fiscal Year EndDecember
  • IPO Date2017-07-12
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.codiagnostics.com
View More

Valuation

  • Trailing PE 12.2
  • Forward PE 7.69
  • Price/Sales (Trailing 12 Mt.) 7.2
  • Price/Book (Most Recent Quarter) 7.37
  • Enterprise Value Revenue 7.61
  • Enterprise Value EBITDA 14.4
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate $0.68
  • Profit Margin 59%
  • Operating Margin 51%
  • Return on Assets 51%
  • Return on Equity 100%
  • Revenue 47.52 million
  • Earnings Per Share $1.12
  • Revenue Per Share $2
  • Gross Profit 102543
  • Quarterly Earnings Growth 52559.1%
View More

Highlights

  • Market Capitalization 387.01 million
  • EBITDA 24.14 million
  • PE Ratio -1.02
  • Analyst Target Price $27
  • Book Value Per Share $1.87
View More

Share Statistics

  • Shares Outstanding 28.27 million
  • Shares Float 26.42 million
  • % Held by Insiders 652%
  • % Held by Institutions 33.01%
  • Shares Short 3.95 million
  • Shares Short Prior Month 4.99 million
  • Short Ratio 1.99
  • Short % of Float 14%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta -1.82
  • 52 Week High $29.99
  • 52 Week Low $6.81
  • 50 Day Moving Average 14.87
  • 200 Day Moving Average 12.87
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Co-Diagnostics, Inc (CODX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Co-Diagnostics, Inc (CODX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A$0.53$0.71-24.82%
2020-06-302020-08-13$N/A$0.43$0.65-33.85%
2020-03-312020-05-14$1.55 million-$0.05-$0.04-25%
2019-12-312020-03-30$N/A-$0.09-$0.09-5.88%
2019-09-302019-11-12$41434-$0.10-$0.08-33.33%
2019-06-302019-08-14$61574-$0.08-$0.06-45.45%
2019-03-312019-05-14$3400-$0.09-$0.08-12.5%
2018-12-312018-12-31$10823-$0.15-$0.13-15.38%
2018-09-302018-11-14$9696-$0.13
2018-06-302018-08-10$9696-$0.11
2018-03-312018-05-14$9696-$0.11
2017-12-312018-03-28$3000-$0.12
2017-09-302017-09-30$3000-$0.33

Co-Diagnostics, Inc (CODX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Co-Diagnostics, Inc (CODX) Chart:

Co-Diagnostics, Inc (CODX) News:

Below you will find a list of latest news for Co-Diagnostics, Inc (CODX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Co-Diagnostics, Inc (CODX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-04-260.50CALL0 00TRUE00
2024-04-2610CALL0 00TRUE00
2024-04-261.50.05CALL0 70FALSE00
2024-04-2620.05CALL0 10FALSE00
2024-04-2630CALL0 00FALSE00
2024-04-263.50CALL0 00FALSE00
2024-04-260.50.05PUT0 20FALSE00
2024-04-2610.15PUT0 40FALSE00
2024-04-261.50PUT0 01205.94TRUE00
2024-04-2620PUT0 01178.87TRUE00
2024-04-2630PUT0 00TRUE00
2024-04-263.50PUT0 00TRUE00
2024-05-030.50CALL0 01291.86TRUE00
2024-05-0310CALL0 0695.81TRUE00
2024-05-031.50.15CALL0 450FALSE00
2024-05-0320.05CALL1 1317.35FALSE0.050
2024-05-030.50PUT0 00FALSE00
2024-05-0310.15PUT0 270FALSE00
2024-05-031.50PUT0 0605.11TRUE00
2024-05-0320PUT0 0662.5TRUE00
2024-05-100.50CALL0 0968.49TRUE00
2024-05-1010CALL0 0521.41TRUE00
2024-05-101.50CALL0 00FALSE00
2024-05-1020CALL0 00FALSE00
2024-05-100.50PUT0 00FALSE00
2024-05-1010.05PUT0 100FALSE00
2024-05-101.50PUT0 0454.88TRUE00
2024-05-1020PUT0 0365.82TRUE00
2024-05-170.50CALL0 0438.14TRUE00
2024-05-1710.2CALL0 161126.02TRUE00
2024-05-171.50CALL0 00FALSE00
2024-05-1720.05CALL0 9370FALSE00
2024-05-1730.05CALL0 1620FALSE00
2024-05-1740.05CALL0 440FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-170.50PUT0 00FALSE00
2024-05-1710.05PUT0 750FALSE00
2024-05-171.50PUT0 0227.32TRUE00
2024-05-1720.83PUT0 278717.3TRUE00
2024-05-1730PUT0 0513.51TRUE00
2024-05-1740PUT0 0819.79TRUE00
2024-05-1750PUT0 0772.67TRUE00
2024-05-240.50CALL0 00TRUE00
2024-05-2410CALL0 0220.5TRUE00
2024-05-241.50.05CALL0 70FALSE00
2024-05-2420CALL0 00FALSE00
2024-05-242.50CALL0 00FALSE00
2024-05-240.50PUT0 00FALSE00
2024-05-2410.05PUT0 200FALSE00
2024-05-241.50PUT0 0373.01TRUE00
2024-05-2420PUT0 0423.38TRUE00
2024-05-242.50PUT0 0414.59TRUE00
2024-05-310.50CALL0 00TRUE00
2024-05-3110CALL0 00TRUE00
2024-05-311.50.15CALL0 20FALSE00
2024-05-3120CALL0 00FALSE00
2024-05-312.50CALL0 00FALSE00
2024-05-310.50PUT0 00FALSE00
2024-05-3110PUT0 00FALSE00
2024-05-311.50PUT0 0180.64TRUE00
2024-05-3120PUT0 0417.16TRUE00
2024-05-312.50PUT0 0850.54TRUE00
2024-06-2110CALL0 0141.46TRUE00
2024-06-2120CALL0 00FALSE00
2024-06-2130CALL0 00FALSE00
2024-06-2140CALL0 00FALSE00
2024-06-2110.1PUT0 10FALSE00
2024-06-2120PUT0 0307.52TRUE00
2024-06-2130PUT0 0356.45TRUE00
2024-06-2140PUT0 0369.38TRUE00
2024-08-1610.33CALL0 399.07TRUE00
2024-08-1620.1CALL0 10850FALSE00
2024-08-1630.05CALL0 70FALSE00
2024-08-1640.05CALL0 210FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-1610.1PUT0 2671.95FALSE00
2024-08-1620.89PUT0 3585.31TRUE00
2024-08-1630PUT0 0155.74TRUE00
2024-08-1640PUT0 0208.77TRUE00
2024-08-1650PUT0 00TRUE00
2024-11-1510CALL0 00TRUE00
2024-11-1520.1CALL0 440FALSE00
2024-11-1530.05CALL0 10FALSE00
2024-11-1540CALL0 00FALSE00
2024-11-1510.15PUT20 3672.54FALSE0.150
2024-11-1520PUT0 096.48TRUE00
2024-11-1530PUT0 0101.31TRUE00
2024-11-1540PUT0 0163.88TRUE00
2025-01-1710.45CALL0 49884.05TRUE00
2025-01-1720.18CALL0 370385.63FALSE00
2025-01-1730.05CALL0 5970FALSE00
2025-01-1740.13CALL0 4500FALSE00
2025-01-1750.08CALL0 3870FALSE00
2025-01-1770.05CALL0 6860FALSE00
2025-01-1710.2PUT0 8287.23FALSE00
2025-01-1720.95PUT0 187100.54TRUE00
2025-01-1731.85PUT0 0159.78TRUE00
2025-01-1742.7PUT0 0263.63TRUE00
2025-01-1750PUT0 0156.88TRUE00
2025-01-1775.84PUT0 0210.92TRUE00

Latest CODX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$5.045
Jun 13, 2022 7:59 PM EST62$5.02
Jun 13, 2022 7:59 PM EST10$5.02
Jun 13, 2022 7:59 PM EST32$5.03
Jun 13, 2022 7:59 PM EST24$5.05

Co-Diagnostics, Inc (CODX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010741/0001493152-20-010741-index.htm
2017-02-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017004539/0000000000-17-004539-index.htm
2017-04-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017013810/0000000000-17-013810-index.htm
2017-05-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017017494/0000000000-17-017494-index.htm
2017-06-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017019457/0000000000-17-019457-index.htm
2018-08-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000018026897/0000000000-18-026897-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000110465919006973/0001104659-19-006973-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000110465920013404/0001104659-20-013404-index.htm
2019-01-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000005/0001469709-19-000005-index.htm
2019-05-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000071/0001469709-19-000071-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2019-05-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000073/0001469709-19-000073-index.htm
2019-05-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000074/0001469709-19-000074-index.htm
2016-12-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793216014416/0001477932-16-014416-index.htm
2017-01-12DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217000164/0001477932-17-000164-index.htm
2017-03-31DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217001422/0001477932-17-001422-index.htm
2017-03-30DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217001424/0001477932-17-001424-index.htm
2017-04-28S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002006/0001477932-17-002006-index.htm
2017-05-24S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002536/0001477932-17-002536-index.htm
2017-05-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002539/0001477932-17-002539-index.htm
2017-06-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002732/0001477932-17-002732-index.htm
2017-06-09FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002739/0001477932-17-002739-index.htm
2017-06-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002758/0001477932-17-002758-index.htm
2017-06-23S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002969/0001477932-17-002969-index.htm
2017-06-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003023/0001477932-17-003023-index.htm
2017-07-10S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217003231/0001477932-17-003231-index.htm
2017-07-118-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003234/0001477932-17-003234-index.htm
2017-07-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003236/0001477932-17-003236-index.htm
2017-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003264/0001477932-17-003264-index.htm
2017-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003272/0001477932-17-003272-index.htm
2017-07-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003279/0001477932-17-003279-index.htm
2017-07-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003297/0001477932-17-003297-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004007/0001477932-17-004007-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004009/0001477932-17-004009-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004011/0001477932-17-004011-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004013/0001477932-17-004013-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004015/0001477932-17-004015-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004017/0001477932-17-004017-index.htm
2017-08-2510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217004217/0001477932-17-004217-index.htm
2017-09-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004384/0001477932-17-004384-index.htm
2017-09-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004581/0001477932-17-004581-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217005611/0001477932-17-005611-index.htm
2017-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2018-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000147793218001468/0001477932-18-001468-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005004/0001493152-18-005004-index.htm
2018-04-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005057/0001493152-18-005057-index.htm
2018-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005251/0001493152-18-005251-index.htm
2018-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005684/0001493152-18-005684-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218006315/0001493152-18-006315-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218006835/0001493152-18-006835-index.htm
2018-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218006942/0001493152-18-006942-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315218011230/0001493152-18-011230-index.htm
2018-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218011357/0001493152-18-011357-index.htm
2018-08-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000149315218011879/0001493152-18-011879-index.htm
2018-09-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000149315218012918/0001493152-18-012918-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218014138/0001493152-18-014138-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218014141/0001493152-18-014141-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315218015065/0001493152-18-015065-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218015919/0001493152-18-015919-index.htm
2018-11-30PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218016927/0001493152-18-016927-index.htm
2018-12-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218017374/0001493152-18-017374-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219000111/0001493152-19-000111-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219000974/0001493152-19-000974-index.htm
2019-02-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219001278/0001493152-19-001278-index.htm
2019-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219001285/0001493152-19-001285-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219001402/0001493152-19-001402-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219002495/0001493152-19-002495-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000149315219004300/0001493152-19-004300-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219006157/0001493152-19-006157-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219007113/0001493152-19-007113-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219009755/0001493152-19-009755-index.htm
2019-07-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219010319/0001493152-19-010319-index.htm
2019-08-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219011962/0001493152-19-011962-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219012480/0001493152-19-012480-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219013719/0001493152-19-013719-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219016885/0001493152-19-016885-index.htm
2019-11-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017799/0001493152-19-017799-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017801/0001493152-19-017801-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017803/0001493152-19-017803-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017826/0001493152-19-017826-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219018053/0001493152-19-018053-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220001137/0001493152-20-001137-index.htm
2020-01-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220001176/0001493152-20-001176-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220001966/0001493152-20-001966-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220002114/0001493152-20-002114-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220002743/0001493152-20-002743-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220003091/0001493152-20-003091-index.htm
2020-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220003154/0001493152-20-003154-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000149315220005305/0001493152-20-005305-index.htm
2020-04-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220006440/0001493152-20-006440-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220008745/0001493152-20-008745-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220008931/0001493152-20-008931-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220009671/0001493152-20-009671-index.htm
2020-06-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010549/0001493152-20-010549-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010553/0001493152-20-010553-index.htm
2020-06-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010556/0001493152-20-010556-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010695/0001493152-20-010695-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010696/0001493152-20-010696-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2020-06-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010741/0001493152-20-010741-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220015523/0001493152-20-015523-index.htm
2020-10-23S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000149315220019890/0001493152-20-019890-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020339/0001493152-20-020339-index.htm
2020-11-0310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220020357/0001493152-20-020357-index.htm
2020-11-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020363/0001493152-20-020363-index.htm
2020-11-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020365/0001493152-20-020365-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561019000066/0001535610-19-000066-index.htm
2020-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561020000007/0001535610-20-000007-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561020000062/0001535610-20-000062-index.htm
2017-07-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999517001776/9999999995-17-001776-index.htm
2018-09-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999518002306/9999999995-18-002306-index.htm
2020-11-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999520003090/9999999995-20-003090-index.htm
2017-07-11CERTNASCertification by the Nasdaq Stock Market approving securities for listinghttps://www.sec.gov/Archives/edgar/data/1692415/999999999717007475/9999999997-17-007475-index.htm

Co-Diagnostics, Inc (CODX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Co-Diagnostics, Inc (CODX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 652%
Institutional Ownership: 3301%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-06America 2030 Capital, LLC10% Share HolderSell1,134,898.000.0111,348.980.00https://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2020-05-20Eugene DurenardDirectorSell25,000.0018.40460,000.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2020-05-26Eugene DurenardDirectorSell25,000.0018.26456,500.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2017-12-13-07:00REED L BENSONCFO and SecretarySell17,792.004.6582,732.800.00https://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2020-05-19RICHARD S SERBINDirectorSell25,000.0018.50462,500.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-05-28RICHARD S SERBINDirectorSell7,500.0018.00135,000.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-05-28RICHARD S SERBINDirectorSell17,500.0018.03315,525.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2018-07-18America 2030 Capital, LLC10% Share HolderSell1,134,897.000.0111,348.971,134,898.00https://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2017-12-13-07:00REED L BENSONCFO and SecretarySell2,776.004.6512,908.4017,792.00https://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2018-04-09Brent SatterfieldChief Science OfficerBuy2,400.004,920.0011,808,000.002,272,198.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005004/0001493152-18-005004-index.htm
2018-04-16Brent SatterfieldChief Science OfficerBuy500.001.94970.002,272,698.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005251/0001493152-18-005251-index.htm
2018-04-23Brent SatterfieldChief Science OfficerBuy500.002.021,010.002,273,198.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005684/0001493152-18-005684-index.htm
2018-05-03Brent SatterfieldChief Science OfficerBuy500.001.91955.002,273,695.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218006315/0001493152-18-006315-index.htm
2018-05-11Brent SatterfieldChief Science OfficerBuy1,305.001.822,375.102,275,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218006942/0001493152-18-006942-index.htm
2020-05-20Eugene DurenardDirectorBuy25,000.000.7117,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-05-20Eugene DurenardDirectorBuy25,000.003.9699,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-05-19RICHARD S SERBINDirectorBuy25,000.000.7117,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220009671/0001493152-20-009671-index.htm
2020-05-28RICHARD S SERBINDirectorBuy25,000.003.9699,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010696/0001493152-20-010696-index.htm